EMDR for panic disorder with agoraphobia: Comparison with waiting list and credible attention-placebo control conditions.

Goldstein, Alan; Beurs, Edwin de; Chambless, Dianne L.; Wilson, Kimberly

doi:10.1037/0022-006x.68.6.947

Cited by 68 publications

(67 citation statements)

References 47 publications

(71 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Eye movement desensitization and reprocessing (EMDR) has been used for panic disorder with disappointing results (Feske and Goldstein 1997;Goldstein et al 2000).…”

Section: Monoamine Oxidase Inhibitors (Maoi)mentioning

confidence: 99%

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders – First Revision

Bandelow

Zohar

Hollander

et al. 2008

The World Journal of Biological Psychiatry

696

401

View full text Add to dashboard Cite

In this report, which is an update of a guideline published in 2002 (Bandelow et al. 2002, recommendations for the pharmacological treatment of anxiety disorder, obsessive-compulsive disorder (OCD) and post-traumatic stress disorder (PTSD) are presented. Since the publication of the first version of this guideline, a substantial number of new randomized controlled studies of anxiolytics have been published. In particular, more relapse prevention studies are now available that show sustained efficacy of anxiolytic drugs. The recommendations, developed by the World Federation of Societies of Biological Psychiatry (WFSBP) Task Force for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders, a consensus panel of 30 international experts, are now based on 510 published randomized, placebo-or comparator-controlled clinical studies (RCTs) and 130 open studies and case reports. First-line treatments for these disorders are selective serotonin reuptake inhibitors (SSRIs), serotonin-noradrenaline reuptake inhibitors (SNRIs) and the calcium channel modulator pregabalin. Tricyclic antidepressants (TCAs) are equally effective for some disorders, but many are less well tolerated than the SSRIs/ SNRIs. In treatment-resistant cases, benzodiazepines may be used when the patient does not have a history of substance abuse disorders. Potential treatment options for patients unresponsive to standard treatments are described in this overview. Although these guidelines focus on medications, non-pharmacological were also considered. Cognitive behavioural therapy (CBT) and other variants of behaviour therapy have been sufficiently investigated in controlled studies in patients with anxiety disorders, OCD, and PTSD to support them being recommended either alone or in combination with the above medicines.

show abstract

“…Eye movement desensitization and reprocessing (EMDR) has been used for panic disorder with disappointing results (Feske and Goldstein 1997;Goldstein et al 2000).…”

Section: Monoamine Oxidase Inhibitors (Maoi)mentioning

confidence: 99%

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders – First Revision

Bandelow

Zohar

Hollander

et al. 2008

The World Journal of Biological Psychiatry

696

401

View full text Add to dashboard Cite

show abstract

“…There were two studies identified during recent years that have examined what could be essentially considered "non-exposure treatments". The study by Goldstein et al (2000) on EMDR concluded that the effect sizes of both EMDR and their non-specific treatment were poor and within the expected limits of a placebo. Therapists were reported to favor the active approach in EMDR, so allegiance should not be considered a serious threat to this conclusion.…”

Section: Treatment Efficacymentioning

confidence: 99%

“…Goldstein, de Beurs, Chambless and Wilson (2000) tried EMDR (EyeMovement Desensitization and Reprocessing Therapy) for patients diagnosed with panic disorder and moderate to severe agoraphobia, in comparison to waiting list control or a credible psychological attention-placebo. Although EMDR was significantly better than the waiting-list on some measures, its difference between attention-placebo was not significant on any measure.…”

Section: Miscellaneousmentioning

confidence: 99%

Behavioral Treatments of Panic Disorder with Agoraphobia: Treatment Process and Determinants of Change

Ramnerö¹

2005

PsycEXTRA Dataset

View full text Add to dashboard Cite

The present dissertation comprises four empirical studies within the area of behavioral treatment of panic disorder with agoraphobia. The focus is on studying issues pertaining to outcome, treatment process and determinants of change. The first study is a randomized controlled treatment study of 73 patients undergoing 16 sessions of either exposure in vivo (E), or cognitive behavior therapy (CBT). Both treatments showed clear improvements at post-treatment that were well maintained at 1-year follow up, and there were no significant differences between the treatments. The second study concerned prediction of outcome in the same sample. From a variety of pre-treatment characteristics severity of avoidance was the one most related to outcome. Most predictors were found unrelated. Two approaches of prediction were also compared: treating outcome as a categorical vs. continuous variable. The different approaches yielded a somewhat dissimilar picture of the impact of pre-treatment severity of avoidance. The third study examined different aspects of the therapeutic relationship, and their relation to outcome. Clients' perceptions of therapists and their ratings of the working alliance were generally not related to outcome at any point. On the other hand, therapists' perceptions of patients as showing goal-direction and active participation were related to outcome from early on in therapy. The fourth study examined different aspects of change. It was found that change in indices of the frequency of panic attacks was not closely related to change in agoraphobic avoidance at post-treatment. Change in avoidance was also more related to other aspects of outcome. At one-year follow-up, a more unitary picture, regarding the different aspects of change was observed.

show abstract

“…Beside incidental reports of therapists suggesting that EMDR can be successfully applied to panic disorder with agoraphobia (de Jongh & ten Broeke, 1996;Fernandez & Faretta, 2007), not many studies have been published, and those that have been conducted were carried out by the same research group (Feske & Goldstein, 1997;Goldstein, de Beurs, Chambless, & Wilson, 2001;Goldstein & Feske, 1994). Their fi rst publication that concerned a series of seven persons diagnosed with panic disorder yielded promising results (Goldstein & Feske, 1994).…”

Section: Panic Disorder With or Without Agoraphobiamentioning

confidence: 99%

“…However, at the 3-month follow-up, these differences could not be maintained. Four years later, the same research group published another randomized clinical trial for panic disorder with agoraphobia (Goldstein et al, 2001) in which the effectiveness of EMDR was compared with a relaxation condition used as an attention-placebo control condition (association and relaxation therapy [ART]). The use of ART in this study appeared to be very similar to EMDR with the exception of EMDR's distraction/bilateral stimulation component.…”

Section: Panic Disorder With or Without Agoraphobiamentioning

confidence: 99%

EMDR and the Anxiety Disorders: Exploring the Current Status

Jongh¹,

Broeke²

2009

J EMDR Prac Res

View full text Add to dashboard Cite

Based on the assumptions of Shapiro’s adaptive information-processing model, it could be argued that a large proportion of people suffering from an anxiety disorder would benefit from eye movement desensitization and reprocessing (EMDR). This article provides an overview of the current empirical evidence on the application of EMDR for the anxiety disorders spectrum other than posttraumatic stress disorder (PTSD). Reviewing the existing literature, it is disappointing to find that 20 years after its introduction, support for the efficacy of EMDR for other conditions than PTSD is still scarce. Randomized outcome research is limited to panic disorder with agoraphobia and spider phobia. The results suggest that EMDR is generally more effective than no-treatment control conditions or nonspecific interventions but less effective than existing evidence-based (i.e., exposure-based) interventions. However, since these studies were based on incomplete protocols and limited treatment courses, questions about the relative efficacy of EMDR for the treatment of anxiety disorders remain largely unanswered.

show abstract

EMDR for panic disorder with agoraphobia: Comparison with waiting list and credible attention-placebo control conditions.

Cited by 68 publications

References 47 publications

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders – First Revision

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders – First Revision

Behavioral Treatments of Panic Disorder with Agoraphobia: Treatment Process and Determinants of Change

EMDR and the Anxiety Disorders: Exploring the Current Status

Contact Info

Product

Resources

About